The modular architecture of meningococcal factor H-binding protein
- 1 September 2009
- journal article
- research article
- Published by Microbiology Society in Microbiology
- Vol. 155 (9) , 2873-2883
- https://doi.org/10.1099/mic.0.029876-0
Abstract
Meningococcal factor H binding protein (fHbp) is a promising vaccine antigen that binds the human complement downregulatory molecule factor H (fH), and this binding enhances the survival of the organism in serum. Based on sequence variability of the entire protein, fHbp has been divided into three variant groups or two subfamilies. Here, we present evidence based on phylogenetic analysis of 70 unique fHbp amino acid sequences that the molecular architecture is modular. From sequences of natural chimeras we identified blocks of two to five invariant residues that flanked five modular variable segments. Although overall, 46 % of the fHbp amino acids were invariant, based on a crystal structure, the invariant blocks that flanked the modular variable segments clustered on the membrane surface containing the amino-terminal lipid anchor, while the remaining invariant residues were located throughout the protein. Each of the five modular variable segments could be classified into one of two types, designated α or β, based on homology with segments encoded by variant 1 or 3 fHbp genes, respectively. Forty of the fHbps (57 %) comprised only α (n=33) or β (n=7) type segments. The remaining 30 proteins (43 %) were chimeras and could be classified into one of four modular groups. These included all 15 proteins assigned to the previously described variant 2 in subfamily A. The modular segments of one chimeric modular group had 96 % amino acid identity with those of fHbp orthologs in Neisseria gonorrhoeae. Collectively, the data suggest that recombination between Neisseria meningitidis and N. gonorrhoeae progenitors generated a family of modular, antigenically diverse meningococcal fHbps.Keywords
This publication has 33 references indexed in Scilit:
- Ex Vivo Model of Meningococcal Bacteremia Using Human Blood for Measuring Vaccine-Induced Serum Passive Protective ActivityClinical and Vaccine Immunology, 2009
- A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groupsMolecular Immunology, 2009
- Meningococcal Factor H–Binding Protein Variants Expressed by Epidemic Capsular Group A, W‐135, and X Strains from AfricaThe Journal of Infectious Diseases, 2009
- Neisseria meningitidis recruits factor H using protein mimicry of host carbohydratesNature, 2009
- Bactericidal Antibody Responses Induced by Meningococcal Recombinant Chimeric Factor H-Binding Protein VaccinesInfection and Immunity, 2008
- Phylogeny.fr: robust phylogenetic analysis for the non-specialistNucleic Acids Research, 2008
- Domain annotation of trimeric autotransporter adhesins—daTAABioinformatics, 2008
- Clustal W and Clustal X version 2.0Bioinformatics, 2007
- Prevalence of Factor H–Binding Protein Variants and NadA among Meningococcal Group B Isolates from the United States: Implications for the Development of a Multicomponent Group B VaccineThe Journal of Infectious Diseases, 2007
- MUSCLE: multiple sequence alignment with high accuracy and high throughputNucleic Acids Research, 2004